Abstract: The invention provides novel halogenated pyrazolo[1,5-a]pyrimidines of formula (I) wherein R, R1, X and Y have different meanings, and pharmaceutically acceptable salts thereof. Compounds of formula (I) are useful for treating or preventing anxiety, epilepsy and sleep disorders including insomnia, and for inducing sedation-hypnosis, anesthesia, sleep and muscle relaxation. The invention also provides synthetic procedures for preparing said compounds and certain intermediates, as well as intermediates themselves.
Type:
Application
Filed:
August 13, 2013
Publication date:
December 22, 2016
Applicant:
Ferrer Internactional, S.A.
Inventors:
Luis Anglada, Albert Palomer, Antonio Guglietta
Abstract: The invention provides novel halogenated pyrazolo[1,5-a]pyrimidines of formula (I) wherein R, R1, X and Y have different meanings, and pharmaceutically acceptable salts thereof. Compounds of formula (I) are useful for treating or preventing anxiety, epilepsy and sleep disorders including insomnia, and for inducing sedation-hypnosis, anesthesia, sleep and muscle relaxation. The invention also provides synthetic procedures for preparing said compounds and certain intermediates, as well as intermediates themselves.
Type:
Application
Filed:
August 13, 2013
Publication date:
December 12, 2013
Applicant:
Ferrer Internactional, S.A.
Inventors:
Luis Anglada, Albert Palomer, Antonio Guglietta